Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/24/24 17:14 | 9/24/24 | RZLT | Health | Drug | Pharmaceutical Preparations | Hogenhuis Wladimir | CA | D | 2 | P | 40 | 4.41 | 0 | 9 | 28 | 42 | D | |||||||||||||||
6/14/24 12:51 | 6/14/24 | RZLT | Health | Drug | Pharmaceutical Preparations | Roberts Brian Kenneth | CA | O | Chief Me | 8 | P.m | 94 | 2.27 | 0 | 42 | 153 | 69 | M | ||||||||||||||
6/14/24 12:06 | 6/14/24 | RZLT | Health | Drug | Pharmaceutical Preparations | Evans Daron | CA | O | CFO | 6 | P.m | 370 | 2.25 | 0 | 164 | 421 | 203 | I | ||||||||||||||
3/19/24 15:47 | 10/15/21 | RZLT | Health | Drug | Pharmaceutical Preparations | Handok, Inc. | M5 | DT | 1 | P.m | 17,000 | 4.33 | 0 | 3,927 | 195 | 5,943 | D | |||||||||||||||
3/14/24 10:35 | 7/22/22 | RZLT | Health | Drug | Pharmaceutical Preparations | Kim Young-Jin | CA | D | 1 | P.m | 370 | 3.20 | 0 | 115 | 2 | 6,058 | D | |||||||||||||||
2/28/24 11:40 | 2/26/24 | RZLT | Health | Drug | Pharmaceutical Preparations | Elam Nevan C | CA | DO | CEO | 1 | P | 8 | 1.68 | 0 | 5 | 177 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |